Kappa Bioscience
Search


Searchresults

Bioequivalence

... The Møller study demonstrated that K2VITAL® is bioequivalent to the natural-fermented K2...

k2-academy/bioequivalence/#c523

Bioequivalence

... of ucOC decreased at the end of the study, when compared to study start, while cOC levels...

k2-academy/bioequivalence/

Commercial

... ingredient worldwide Estimates show that the K2 market has been doubling each year. With market figures...

k2-academy/commercial/#c443

Bioequivalence

... The Møller study has proven that all benefits obtained with the natural-fermented MK-7 are equally valid for K2VITAL®...

k2-academy/bioequivalence/#c525

Experience K2

... concepts that are available for global market introduction. Each ExperienceCard concept...

experience-k2/

Commercial

... time. The move of vitamin K2 MK-7 into mainstream markets is now underway. Vitamin K2 MK-7 is on the path...

k2-academy/commercial/#c445

Pregnancy

... K2 in their breast milk by taking K2 Another study showed increased levels of vitamin K in the breast...

k2-academy/pregnancy/#c474

Commercial

... Commercial Market Development – Commercial See what CEO Egil Greve from Kappa Bioscience has to say about K2 left...

k2-academy/commercial/#c448

K2Softgum

... developed based on this concept and placed on the market, then the distributor is responsible for examining...

experience-k2/k2softgum/

Pregnancy

... K2 supplementation. In a controlled Japanese study, women given 20 mg of vitamin K2 about a week before...

k2-academy/pregnancy/
Search results 1 until 10 of 30

Customer Download Portal

Sign up | Reset password

Sales and Marketing
Kappa Ingredients GmbH
Deichstrasse 29 | 20459 Hamburg
Germany

Headquarter
Kappa Bioscience AS
Silurveien 2 | Building B | 0380 Oslo
Norway

+49 40 6094087 0